These findings were evidenced by the observed attenuation of CBD’s pro-apoptotic and cytotoxic effects when the COX-2 and PPARɣ activities were suppressed with active antagonists or siRNA in NSCLC lines [1,33]. This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.